DCM
ANGO icon

Delpha Capital Management’s AngioDynamics ANGO Stock Holding History

Delpha Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-846
Closed -$14K – 187
2017
Q4 		$14K Buy
+846
New +$14.4K 0.02% 916

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Delpha Capital Management's ANGO Position: Q1 2018 in Review

Delpha Capital Management sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 846 shares — an estimated $14K sold.

Delpha Capital Management first reported a position in ANGO in Q4 2017 and held it in 1 quarter. The position peaked at $14K in Q4 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

  • Delpha Capital Management reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 846 AngioDynamics shares in Q1 2018, an estimated $14K.
  • Delpha Capital Management first reported a position in AngioDynamics in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's AngioDynamics position peaked at $14K in Q4 2017.
  • 164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.